In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug-Reference-Cited by-同舟云学术

In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug

Published:2016-05-03 Issue:18 Volume:133 Page:1783-1794
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Hopper Rachel K.¹,Moonen Jan-Renier A.J.¹,Diebold Isabel¹,Cao Aiqin¹,Rhodes Christopher J.¹,Tojais Nancy F.¹,Hennigs Jan K.¹,Gu Mingxia¹,Wang Lingli¹,Rabinovitch Marlene¹

Affiliation:

1. From Department of Pediatrics, the Vera Moulton Wall Center for Pulmonary Vascular Disease and the Cardiovascular Institute, Stanford University School of Medicine, CA (R.K.H., J.-R.A.J.M., A.C., C.J.R., N.F.T., J.K.H., M.G., L.W., M.R.); Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania and Children’s Hospital of Philadelphia (R.K.H.); Center for Congenital Heart Diseases, Pediatric Cardiology, Beatrix Children’s Hospital, University Medical Center Groningen,...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference50 articles.

1. Molecular pathogenesis of pulmonary arterial hypertension

2. Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease.;Jones PL;Am J Pathol,1997

3. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension

4. Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond VICs: Shedding light on the overlooked VECs in calcific aortic valve disease;Biomedicine & Pharmacotherapy;2024-09

2. Mechanisms and treatment of pulmonary arterial hypertension;Nature Reviews Cardiology;2024-08-07

3. Frataxin Loss Promotes Angiotensin II–Induced Endothelial‐to‐Mesenchymal Transition;Journal of the American Heart Association;2024-08-06

4. Molecular Changes Implicate Angiogenesis and Arterial Remodeling in Systemic Sclerosis–Associated and Idiopathic Pulmonary Hypertension;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-08

5. Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction;American Journal of Respiratory Cell and Molecular Biology;2024-07